![Daniel Janse](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel Janse
Direktor/Vorstandsmitglied bei Triumvira Immunologics USA, Inc.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Paul Lammers | M | 66 |
Triumvira Immunologics USA, Inc.
![]() Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | 6 Jahre |
Dan Ahlstedt | M | - |
EnPlusOne Biosciences, Inc
![]() EnPlusOne Biosciences, Inc Packaged SoftwareTechnology Services EnPlusOne Biosciences, Inc is a company that develops an enzymatic synthesis platform to unlock site-specific and diverse RNA modification. The company is based in Watertown, MA. The company was founded by Dan Ahlstedt, George Church, Howon Lee, Daniel Wiegand, Jonathan Rittichier. Daniel Wiegand has been the CEO since incorporation. | - |
Daniel Wiegand | M | - |
EnPlusOne Biosciences, Inc
![]() EnPlusOne Biosciences, Inc Packaged SoftwareTechnology Services EnPlusOne Biosciences, Inc is a company that develops an enzymatic synthesis platform to unlock site-specific and diverse RNA modification. The company is based in Watertown, MA. The company was founded by Dan Ahlstedt, George Church, Howon Lee, Daniel Wiegand, Jonathan Rittichier. Daniel Wiegand has been the CEO since incorporation. | - |
Robert Williamson | M | 58 |
Triumvira Immunologics USA, Inc.
![]() Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | 2 Jahre |
Kelli Luginbuhl | F | - |
Isolere Bio, Inc.
![]() Isolere Bio, Inc. Pharmaceuticals: MajorHealth Technology Part of Donaldson Co., Inc., Isolere Bio, Inc. is an early-stage biotechnology company that develops novel and proprietary reagents. The company is based in Durham, NC. The company was founded in 2017 by Kelli Luginbuhl, Joseph McMahon, Ashutosh Chilkoti. Kelli Luginbuhl has been the CEO since 2017. Isolere Bio was acquired by Donaldson Co., Inc. on February 21, 2023 for $62.50 million. | 7 Jahre |
Ashutosh Chilkoti | M | - |
Isolere Bio, Inc.
![]() Isolere Bio, Inc. Pharmaceuticals: MajorHealth Technology Part of Donaldson Co., Inc., Isolere Bio, Inc. is an early-stage biotechnology company that develops novel and proprietary reagents. The company is based in Durham, NC. The company was founded in 2017 by Kelli Luginbuhl, Joseph McMahon, Ashutosh Chilkoti. Kelli Luginbuhl has been the CEO since 2017. Isolere Bio was acquired by Donaldson Co., Inc. on February 21, 2023 for $62.50 million. | 7 Jahre |
Jonathan Rittichier | M | - |
EnPlusOne Biosciences, Inc
![]() EnPlusOne Biosciences, Inc Packaged SoftwareTechnology Services EnPlusOne Biosciences, Inc is a company that develops an enzymatic synthesis platform to unlock site-specific and diverse RNA modification. The company is based in Watertown, MA. The company was founded by Dan Ahlstedt, George Church, Howon Lee, Daniel Wiegand, Jonathan Rittichier. Daniel Wiegand has been the CEO since incorporation. | - |
Joseph McMahon | M | - |
Isolere Bio, Inc.
![]() Isolere Bio, Inc. Pharmaceuticals: MajorHealth Technology Part of Donaldson Co., Inc., Isolere Bio, Inc. is an early-stage biotechnology company that develops novel and proprietary reagents. The company is based in Durham, NC. The company was founded in 2017 by Kelli Luginbuhl, Joseph McMahon, Ashutosh Chilkoti. Kelli Luginbuhl has been the CEO since 2017. Isolere Bio was acquired by Donaldson Co., Inc. on February 21, 2023 for $62.50 million. | 7 Jahre |
Cynthia Collins | F | 65 |
Triumvira Immunologics USA, Inc.
![]() Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | - |
Andrew Lee | M | - |
EnPlusOne Biosciences, Inc
![]() EnPlusOne Biosciences, Inc Packaged SoftwareTechnology Services EnPlusOne Biosciences, Inc is a company that develops an enzymatic synthesis platform to unlock site-specific and diverse RNA modification. The company is based in Watertown, MA. The company was founded by Dan Ahlstedt, George Church, Howon Lee, Daniel Wiegand, Jonathan Rittichier. Daniel Wiegand has been the CEO since incorporation. | - |
Jürgen Eckhardt | M | 57 |
Triumvira Immunologics USA, Inc.
![]() Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | 4 Jahre |
Lee Cooper | M | - |
Triumvira Immunologics USA, Inc.
![]() Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | 4 Jahre |
Scott Smith | M | 61 |
Triumvira Immunologics USA, Inc.
![]() Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | - |
Steven H. Kasok | M | - |
EnPlusOne Biosciences, Inc
![]() EnPlusOne Biosciences, Inc Packaged SoftwareTechnology Services EnPlusOne Biosciences, Inc is a company that develops an enzymatic synthesis platform to unlock site-specific and diverse RNA modification. The company is based in Watertown, MA. The company was founded by Dan Ahlstedt, George Church, Howon Lee, Daniel Wiegand, Jonathan Rittichier. Daniel Wiegand has been the CEO since incorporation. | - |
Brian Bloom | M | 48 |
Triumvira Immunologics USA, Inc.
![]() Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | 4 Jahre |
Elizabeth Williams | F | - |
Triumvira Immunologics USA, Inc.
![]() Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | - |
Widya Mulyasasmita | M | - |
Triumvira Immunologics USA, Inc.
![]() Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 17 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Daniel Janse
- Persönliches Netzwerk